Anan Chuntharapai

This inventor holds 31 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 13 EPO patents. Top assignees: Genentech, Inc., Genetech, Inc.. Active years: 1996-2022.

USPTO Granted Patents = 31 (Patent Applications = 9)

% Patents Active = 61.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 8)

Average Co-Inventor Count = 4.1

ph-index = 12

Forward Citations = 420(Granted Patents)

Location History:

South San Francisco, CA (US) (2013)
Colma, CA (US) (1996 - 2022)

Company Filing History:

Years Active: 1996-2022

Loading Chart...

Areas of Expertise:

Anti-PD-L1 Antibodies

Cytokine Signaling

Apoptotic Anti-IgE Antibodies

Anti-Interferon Antibodies

Apo-2 Receptor Agonist Antibodies

Monoclonal Antibodies

Tumor Diagnosis

Cancer Treatment

Integrin Antibodies

IL-8 Type A Receptor Antibodies

Osteoclast Integrin

Nucleic Acid Encoding

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11292843 - Anti-PD-L1 antibodies and methods of using the same for detection of PD-L1 (2022-04-05),

2. 9555107 - Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling (2017-01-31),

3. 8632775 - Apoptotic anti-IgE antibodies (2014-01-21),

4. 8618274 - Nucleic acid encoding apoptotic anti-IgE antibodies (2013-12-31),

5. 8586040 - Methods of using apoptotic anti-IGE antibodies (2013-11-19),

6. 8557967 - Anti-interferon-α antibodies (2013-10-15),

7. 8350010 - Anti-alpha5/beta1 antibody (2013-01-08),

8. 8349331 - Anti-interferon-α antibodies (2013-01-08),

9. 8092799 - Antibodies to Apo-2 receptor polypeptides (2012-01-10),

10. 8071097 - Apoptotic anti-IgE antibodies (2011-12-06),

11. 7910707 - Anti-interferon-α antibodies (2011-03-22),

12. 7807153 - Apo-2 receptor agonist antibodies (2010-10-05),

13. 7803915 - Antibody compositions for the diagnosis and treatment of tumor (2010-09-28),

14. 7744881 - Human DR4 antibodies and uses thereof (2010-06-29),

15. 7737259 - Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling (2010-06-15),

Title: The Innovative Mind of Anan Chuntharapai

Introduction: Anan Chuntharapai is a visionary inventor based in Colma, California. His passion for creating groundbreaking solutions has led to numerous patents and collaborations in the field of innovations.

Latest Patents: Anan Chuntharapai holds several recent patents in the areas of renewable energy technologies, sustainable materials, and advanced robotics. His inventions have been recognized for their potential to revolutionize industries and improve the quality of life.

Career Highlights: With a background in engineering and a keen interest in emerging technologies, Anan Chuntharapai has dedicated his career to pushing the boundaries of what is possible. His innovative spirit has driven him to explore new frontiers and develop cutting-edge solutions to complex challenges.

Collaborations: Anan Chuntharapai has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work across disciplines and bring together diverse teams has been instrumental in the success of his projects.

Conclusion: Anan Chuntharapai's relentless pursuit of innovation and his commitment to making a positive impact on the world make him a true pioneer in the field of inventions. His work continues to inspire others to think creatively and push the boundaries of what is possible in the world of technology.